Structural Analysis of the Colony-Stimulating Factor 3 Gene of Granulocyte Colony-Stimulating Factor-Producing Urothelial Cancer

被引:0
作者
Okuno, Yumiko [1 ]
Hori, Mai [1 ]
-Kato, Mami Hattori [1 ]
Fukuhara, Hiroshi [2 ]
Nomiya, Akira [1 ]
Mikami, Koji [1 ]
Takeuchi, Takumi [1 ]
机构
[1] Kanto Rosai Hosp, Dept Urol, Japan Org Occupat Hlth & Safety, Kawasaki, Japan
[2] Kyorin Univ, Fac Med, Dept Urol, Tokyo, Japan
关键词
transcription; mutation; csf3; g-csf; urothelial cancer; CARCINOMA; PEMBROLIZUMAB; EXPRESSION; CDNA;
D O I
10.7759/cureus.43981
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Granulocyte colony-stimulating factor (G-CSF) is a member of the CSF family of glycoproteins that regulate the proliferation, differentiation, and mobilization of neutrophils. G-CSF-producing malignant cancers have been reported to occur in various organs and are mostly associated with poor clinical prognosis. Here, we analyzed the structure of the CSF3 gene encoding the G-CSF protein to delineate the mechanism of G-CSF production by the cancer cells. Methodology Two cases of G-CSF-producing urothelial cancers and three cases of G-CSF-nonproducing bladder cancers were enrolled for genetic analysis. Results In one case of G-CSF-producing bladder cancer, six somatic mutations were detected in the 5'-upstream region of the CSF3 gene. No somatic mutations in the CSF3 gene were detected in another case of G-CSF-producing renal pelvic cancer and G-CSF-nonproducing bladder cancers. Copy numbers of the CSF3 gene were not increased in G-CSF-producing urothelial cancers. Conclusions Somatic mutations in the 5'-upstream region of the CSF3 gene may cause G-CSF protein overproduction.
引用
收藏
页数:9
相关论文
共 21 条
[1]  
ANGER B, 1982, CANCER-AM CANCER SOC, V50, P1518, DOI 10.1002/1097-0142(19821015)50:8<1518::AID-CNCR2820500812>3.0.CO
[2]  
2-R
[3]   Pembrolizumab as Second-Line Therapy for Advanced Urothelial Carcinoma [J].
Bellmunt, J. ;
de Wit, R. ;
Vaughn, D. J. ;
Fradet, Y. ;
Lee, J. -L. ;
Fong, L. ;
Vogelzang, N. J. ;
Climent, M. A. ;
Petrylak, D. P. ;
Choueiri, T. K. ;
Necchi, A. ;
Gerritsen, W. ;
Gurney, H. ;
Quinn, D. I. ;
Culine, S. ;
Sternberg, C. N. ;
Mai, Y. ;
Poehlein, C. H. ;
Perini, R. F. ;
Bajorin, D. F. .
NEW ENGLAND JOURNAL OF MEDICINE, 2017, 376 (11) :1015-1026
[4]   Impact of mutations in Toll-like receptor pathway genes on esophageal carcinogenesis [J].
Elliott, Daffolyn Rachael Fels ;
Perner, Juliane ;
Li, Xiaodun ;
Symmons, Martyn F. ;
Verstak, Brett ;
Eldridge, Matthew ;
Bower, Lawrence ;
O'Donovan, Maria ;
Gay, Nick J. ;
Fitzgerald, Rebecca C. .
PLOS GENETICS, 2017, 13 (05)
[5]   GeneHancer: genome-wide integration of enhancers and target genes in GeneCards [J].
Fishilevich, Simon ;
Nudel, Ron ;
Rappaport, Noa ;
Hadar, Rotem ;
Plaschkes, Inbar ;
Stein, Tsippi Iny ;
Rosen, Naomi ;
Kohn, Asher ;
Twik, Michal ;
Safran, Marilyn ;
Lancet, Doron ;
Cohen, Dana .
DATABASE-THE JOURNAL OF BIOLOGICAL DATABASES AND CURATION, 2017,
[6]  
Kasuga I, 2001, CANCER-AM CANCER SOC, V92, P2399, DOI 10.1002/1097-0142(20011101)92:9<2399::AID-CNCR1588>3.0.CO
[7]  
2-W
[8]   Emergency granulopoiesis [J].
Manz, Markus G. ;
Boettcher, Steffen .
NATURE REVIEWS IMMUNOLOGY, 2014, 14 (05) :302-314
[9]   Programmed cell death ligand 1 measurement study in granulocyte colony-stimulating factor-producing lung cancer: an observational study [J].
Miyazaki, Kazuhito ;
Shiba, Aya ;
Ikeda, Toshiki ;
Higashi, Yuko ;
Aga, Masaharu ;
Hamakawa, Yusuke ;
Taniguchi, Yuri ;
Misumi, Yuki ;
Agemi, Yoko ;
Nakamura, Yukiko ;
Shimokawa, Tsuneo ;
Okamoto, Hiroaki .
BMC CANCER, 2022, 22 (01)
[10]   G-CSF and G-CSFR are highly expressed in human gastric and colon cancers and promote carcinoma cell proliferation and migration [J].
Morris, K. T. ;
Khan, H. ;
Ahmad, A. ;
Weston, L. L. ;
Nofchissey, R. A. ;
Pinchuk, I. V. ;
Beswick, E. J. .
BRITISH JOURNAL OF CANCER, 2014, 110 (05) :1211-1220